HB 172

  • New Hampshire House Bill
  • 2024 Regular Session
  • Introduced in House Jan 03, 2023
  • House
  • Senate
  • Governor

relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

Votes


No votes to display

Actions


Jan 03, 2024

House

Inexpedient to Legislate: MA VV 01/03/2024 HJ 1 P. 34

Nov 16, 2023

House

Committee Report: Inexpedient to Legislate HB172 11/08/2023 (Vote 19-0; CC) HC 49 P. 3

Nov 08, 2023

House

==CANCELLED== Executive Session: 11/15/2023 11:00 am LOB 302-304 HC 42

Oct 17, 2023

House

==RECESSED== Executive Session: 11/08/2023 01:30 pm LOB 302-304 HC 42

Sep 06, 2023

House

==RESCHEDULED== Subcommittee Work Session: 09/20/2023 01:15 pm LOB 302-304 HC 36

Aug 30, 2023

House

==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm LOB 302-304

Mar 13, 2023

House

Retained in Committee

Feb 23, 2023

House

Subcommittee Work Session: 03/08/2023 10:00 am LOB 302-304

House

Executive Session: 03/08/2023 01:15 pm LOB 302-304

Feb 01, 2023

House

Subcommittee Work Session: 02/08/2023 10:45 am LOB 302-304

Jan 19, 2023

House

Public Hearing: 01/26/2023 10:00 am LOB 302-304

Jan 03, 2023

House

Introduced 01/04/2023 and referred to Commerce and Consumer Affairs

Bill Text

Bill Text Versions Format
No related documents.

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New Hampshire General Court.

If you notice any inconsistencies with these official sources, feel free to file an issue.